Privium Fund Management B.V.
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
59 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 33.9% | $162,565,249 |
| Consumer Cyclical | 25.0% | $119,990,030 |
| Technology | 24.2% | $116,289,550 |
| Financial Services | 8.5% | $40,768,566 |
| Communication Services | 6.8% | $32,488,970 |
| Energy | 0.8% | $3,872,370 |
| Consumer Defensive | 0.6% | $2,769,789 |
| Basic Materials | 0.3% | $1,353,722 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PRQR | ProQR Therapeutics N.V. | +109,387 | 5,467,149 | $8,856,781 | |
| RCKT | Rocket Pharmaceuticals, Inc. | +72,000 | 242,146 | $866,882 | |
| QURE | uniQure N.V. | +70,250 | 486,520 | $7,954,602 | |
| IONS | Ionis Pharmaceuticals Inc | +49,200 | 290,024 | $21,777,902 | |
| WVE | Wave Life Sciences Ltd. | +48,000 | 241,010 | $1,747,322 | |
| FATE | Fate Therapeutics Inc | +45,211 | 414,311 | $497,173 | |
| IREN | IREN Ltd | +40,150 | 320,150 | $10,974,742 | |
| AUTL | Autolus Therapeutics plc | +37,185 | 363,430 | $501,533 | |
| VYGR | Voyager Therapeutics, Inc. | +25,000 | 120,000 | $463,200 | |
| URGN | UroGen Pharma Ltd. | +23,500 | 238,122 | $4,281,433 | |
| TSHA | Taysha Gene Therapies, Inc. | +17,000 | 181,900 | $813,093 | |
| ARQT | Arcutis Biotherapeutics, Inc. | +15,000 | 320,972 | $7,562,100 | |
| PFE | Pfizer Inc | +14,929 | 52,679 | $1,479,226 | |
| LXEO | Lexeo Therapeutics, Inc. | +12,450 | 205,000 | $1,176,700 | |
| MGTX | MeiraGTx Holdings plc | +12,112 | 212,112 | $1,836,889 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +7,300 | 364,802 | $7,642,601 | |
| LMND | Lemonade, Inc. | +7,000 | 255,259 | $15,999,634 | |
| RNAC | Cartesian Therapeutics, Inc. | +6,614 | 179,114 | $1,101,551 | |
| AMZN | Amazon Com Inc | +4,000 | 125,000 | $26,033,750 | |
| SRPT | Sarepta Therapeutics, Inc. | +3,000 | 46,000 | $1,000,960 | |
| AMD | Advanced Micro Devices Inc | +2,000 | 62,000 | $12,612,660 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | +2,000 | 11,355 | $5,070,461 | |
| AXSM | Axsome Therapeutics, Inc. | +1,851 | 58,729 | $9,926,375 | |
| SA | Seabridge Gold Inc | +1,072 | 24,828 | $703,625 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ABEV | Ambev S.A. | −114,616 | 948,558 | $2,769,789 | |
| FDMT | 4D Molecular Therapeutics, Inc. | −39,744 | 170,256 | $1,585,083 | |
| RIG | Transocean Ltd. | −33,000 | 106,604 | $706,784 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | −31,268 | 366,936 | $23,006,887 | |
| BIIB | Biogen Inc. | −29,680 | 43,800 | $8,029,854 | |
| SLB | Slb Limited/Nv | −20,354 | 18,451 | $948,196 | |
| MRNA | Moderna, Inc. | −19,600 | 29,994 | $1,523,695 | |
| NOV | NOV Inc. | −11,100 | 42,026 | $790,509 | |
| BEAM | Beam Therapeutics Inc. | −7,518 | 63,982 | $1,524,691 | |
| TSLA | Tesla, Inc. | −6,500 | 222,000 | $82,528,500 | |
| BNTX | BioNTech SE | −6,300 | 27,000 | $2,399,760 | |
| STOK | Stoke Therapeutics, Inc. | −5,000 | 50,000 | $1,628,000 | |
| NE | Noble Corp plc | −4,000 | 6,849 | $336,080 | |
| SHOP | Shopify Inc. | −3,000 | 407,000 | $48,278,340 | |
| SPOT | Spotify Technology S.A. | −1,000 | 67,000 | $32,488,970 | |
| KRYS | Krystal Biotech, Inc. | −1,000 | 11,170 | $2,885,434 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | 3,299,441 | $9,040,468 | |
| BMRN | Biomarin Pharmaceutical Inc | 92,305 | $5,214,309 | |
| DNLI | Denali Therapeutics Inc. | 254,857 | $4,893,254 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 12,222 | $4,043,893 | |
| MOH | Molina Healthcare, Inc. | 8,140 | $1,085,062 | |
| BTG | B2gold Corp | 96,477 | $437,040 | |
| PAAS | Pan American Silver Corp | 3,900 | $213,057 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TSLA |
Tesla, Inc.
Consumer Cyclical
|
Reduced | 222,000 | $82,528,500 | 17.19% | |
| SHOP |
Shopify Inc.
Technology
|
Reduced | 407,000 | $48,278,340 | 10.06% | |
| SPOT |
Spotify Technology S.A.
Communication Services
|
Reduced | 67,000 | $32,488,970 | 6.77% | |
| PLTR |
Palantir Technologies Inc.
Technology
|
Held | 200,000 | $29,256,000 | 6.09% | |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
Added | 125,000 | $26,033,750 | 5.42% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Reduced | 366,936 | $23,006,887 | 4.79% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 290,024 | $21,777,902 | 4.54% | |
| LMND |
Lemonade, Inc.
Financial Services
|
Added | 255,259 | $15,999,634 | 3.33% | |
| NVDA |
Nvidia Corp
Technology
|
Held | 81,000 | $14,126,400 | 2.94% | |
| COIN |
Coinbase Global, Inc.
Financial Services
|
Held | 79,000 | $13,794,190 | 2.87% | |
| AMD |
Advanced Micro Devices Inc
Technology
|
Added | 62,000 | $12,612,660 | 2.63% | |
| ASTS |
AST SpaceMobile, Inc.
Technology
|
Held | 145,000 | $12,016,150 | 2.50% | |
| SE |
Sea Ltd
Consumer Cyclical
|
Held | 138,000 | $11,427,780 | 2.38% | |
| IREN |
IREN Ltd
Financial Services
|
Added | 320,150 | $10,974,742 | 2.29% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 58,729 | $9,926,375 | 2.07% | |
| ESPR |
Esperion Therapeutics, Inc.
Healthcare
|
NEW | 3,299,441 | $9,040,468 | 1.88% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Added | 5,467,149 | $8,856,781 | 1.84% | |
| BIIB |
Biogen Inc.
Healthcare
|
Reduced | 43,800 | $8,029,854 | 1.67% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 486,520 | $7,954,602 | 1.66% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 364,802 | $7,642,601 | 1.59% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Added | 320,972 | $7,562,100 | 1.58% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
NEW | 92,305 | $5,214,309 | 1.09% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Added | 11,355 | $5,070,461 | 1.06% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
NEW | 254,857 | $4,893,254 | 1.02% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Added | 238,122 | $4,281,433 | 0.89% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
NEW | 12,222 | $4,043,893 | 0.84% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Held | 173,516 | $3,393,972 | 0.71% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Reduced | 11,170 | $2,885,434 | 0.60% | |
| ABEV |
Ambev S.A.
Consumer Defensive
|
Reduced | 948,558 | $2,769,789 | 0.58% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Held | 132,189 | $2,486,475 | 0.52% | |
| BNTX |
BioNTech SE
Healthcare
|
Reduced | 27,000 | $2,399,760 | 0.50% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Held | 352,087 | $2,397,712 | 0.50% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Held | 42,874 | $2,039,516 | 0.42% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
Added | 212,112 | $1,836,889 | 0.38% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Added | 241,010 | $1,747,322 | 0.36% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Reduced | 50,000 | $1,628,000 | 0.34% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
Reduced | 170,256 | $1,585,083 | 0.33% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Reduced | 63,982 | $1,524,691 | 0.32% | |
| MRNA |
Moderna, Inc.
Healthcare
|
Reduced | 29,994 | $1,523,695 | 0.32% | |
| PFE |
Pfizer Inc
Healthcare
|
Added | 52,679 | $1,479,226 | 0.31% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Added | 205,000 | $1,176,700 | 0.25% | |
| RNAC |
Cartesian Therapeutics, Inc.
Healthcare
|
Added | 179,114 | $1,101,551 | 0.23% | |
| MOH |
Molina Healthcare, Inc.
Healthcare
|
NEW | 8,140 | $1,085,062 | 0.23% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Added | 46,000 | $1,000,960 | 0.21% | |
| SLB |
Slb Limited/Nv
Energy
|
Reduced | 18,451 | $948,196 | 0.20% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Added | 242,146 | $866,882 | 0.18% | |
| HIMS |
Hims & Hers Health, Inc.
Healthcare
|
Held | 40,000 | $830,400 | 0.17% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 181,900 | $813,093 | 0.17% | |
| NOV |
NOV Inc.
Energy
|
Reduced | 42,026 | $790,509 | 0.16% | |
| RIG |
Transocean Ltd.
Energy
|
Reduced | 106,604 | $706,784 | 0.15% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.